{'output': [['Amarin Corporation plc', 'ORG', 'Provide', 'Business Update', 'CONCEPT'], ['Amarin Corporation plc', 'ORG', 'Update', '2017 Revenue Guidance', 'ECON_INDICATOR'], ['Amarin Corporation plc', 'ORG', 'Forecast', '2018 Revenue', 'ECON_INDICATOR'], ['Amarin Corporation plc', 'ORG', 'Anticipate', '2018 Net Product Revenue Growth', 'ECON_INDICATOR'], ['Amarin Corporation plc', 'ORG', 'Discuss', 'Results', 'CONCEPT'], ['Amarin Corporation plc', 'ORG', 'Present', 'At 36th Annual J.P. Morgan Healthcare Conference', 'EVENT'], ['Amarin Corporation plc', 'ORG', 'Estimate', '2017 Net Product Revenue', 'ECON_INDICATOR'], ['Amarin Corporation plc', 'ORG', 'Exceed', 'Upper End of Previously Provided Guidance', 'CONCEPT'], ['Amarin Corporation plc', 'ORG', 'Estimate', 'Q4 2017 Net Product Revenue', 'ECON_INDICATOR'], ['Amarin Corporation plc', 'ORG', 'Achieve', 'Record Revenue Levels', 'CONCEPT'], ['Amarin Corporation plc', 'ORG', 'Drive', 'Net Revenue Growth', 'ECON_INDICATOR'], ['Amarin Corporation plc', 'ORG', 'Increase', 'Approximately 37% to 40%', 'ECON_INDICATOR'], ['Amarin Corporation plc', 'ORG', 'End', '2017 with Approximately $73.6 Million in Cash', 'ECON_INDICATOR'], ['Amarin Corporation plc', 'ORG', 'End', '2017 with Approximately $44 Million in Net Accounts Receivable', 'ECON_INDICATOR'], ['Amarin Corporation plc', 'ORG', 'End', '2017 with Approximately $29 Million in Inventory', 'ECON_INDICATOR'], ['Amarin Corporation plc', 'ORG', 'Control', 'Cash Expenditures', 'CONCEPT'], ['Amarin Corporation plc', 'ORG', 'Achieve', 'Greater Contribution from Growing Revenues of Commercial Operations', 'CONCEPT'], ['Amarin Corporation plc', 'ORG', 'Anticipate', 'Further Increasing Valuation Allowance Against Deferred Tax Assets', 'CONCEPT'], ['Amarin Corporation plc', 'ORG', 'Have', 'Over $570 Million in Tax Loss Carryforwards', 'ECON_INDICATOR'], ['Amarin Corporation plc', 'ORG', 'End', '2017 with Debt of $30 Million Face Value of Exchangeable Debt', 'ECON_INDICATOR'], ['Amarin Corporation plc', 'ORG', 'Increase', 'Gross Margin on Product Sales to Approximately 75%', 'ECON_INDICATOR'], ['Amarin Corporation plc', 'ORG', 'Expand', 'Supply Capacity', 'CONCEPT'], ['Amarin Corporation plc', 'ORG', 'Provide', 'Supply to Support Potential of Over $1 Billion in Product Revenues in 2019', 'ECON_INDICATOR'], ['Amarin Corporation plc', 'ORG', 'Benefit', 'More Than 150,000 Patients', 'CONCEPT']]}